1 Patent
- US117536272023Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3′-UTR of Dengue Types 1,2,3, and 4, or Antigenic Chimeric Dengue Viruses 1,2,3, and 4
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites